Skip to main content
. Author manuscript; available in PMC: 2009 Aug 24.
Published in final edited form as: Lancet Neurol. 2009 May;8(5):475–490. doi: 10.1016/S1474-4422(09)70063-8

Table 5.

Adverse events related to treatment of myasthenia gravis with corticosteroids

Strategies for prevention
Sodium/fluid retention Sodium-restricted diet
Obesity Low-calorie, low-fat diet; exercise
Potassium loss Supplement as needed
Hypertension Monthly checks with treatment as necessary
Impaired glucose tolerance Monitor fasting blood glucose and treat if necessary
Osteoporosis Bisphosphonates, calcium plus vitamin D, bone-density measurements, female hormone replacement therapy
Psychosis/anxiety Anxiolytics, antidepressants, use minimum effective steroid dose
Cataracts/glaucoma At least yearly ophthalmological assessment
Steroid myopathy Exercise, high-protein diet
Growth suppression (children) Use minimum effective dose
Peptic ulcer disease Histamine H2 receptor antagonists, proton-pump inhibitors